Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS

阿扎胞苷治疗可使难治性血管免疫母细胞性T细胞淋巴瘤（AITL）在无TET2突变或合并骨髓增生异常综合征（MDS）的情况下快速且持久地达到完全缓解。